Mark E Boulding
Executive Vice President and Chief Legal OfficeratPTC Therapeutics· In proxies 2021–2023
Pay in FY2023-18% from the year before · PTC Therapeutics stock -27.8% the same year
Mark E Boulding was paid $2.2M in FY2023 (Dec), down 18%. PTC Therapeutics stock fell 27.8% that year.
Pay$100 in the stock at the end of FY20 → $45
Experience
- PTC TherapeuticsPublic company · 5 yr
- Executive Vice President and Chief Legal Officer2021 – Present · 5 yrStock in role -3%
Roles come from the proxy statements of each company.
Activity
Two people shown as one, or a wrong number?